Elżbieta Tokarczyk
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Elżbieta Tokarczyk has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Daria Ziemińska
Department and Clinic of Geriatrics and Internal Medicine, Nicolaus Copernicus University in Toruń Ludwik Rydygier Collegium Medicum in Bydgoszcz, ul. Marii Skłodowskiej-Curie 9, 85-094 Bydgoszcz, Poland
4 shared publications - Rafał Burczyk
Department and Clinic of Geriatrics and Internal Medicine, Nicolaus Copernicus University in Toruń, Ludwik Rydygier Collegium Medicum in Bydgoszcz, ul. Marii Curie-Skłodowskiej 9, 85-094 Bydgoszcz, Poland
4 shared publications - Karina Motolko
Specjalistyczny Szpital Miejski im. M. Kopernika w Toruniu, ul. Stefana Batorego 17/19, 87-100 Toruń
3 shared publications - Konrad Duszyński
Studenckie Koło Naukowe Okulistyki, Gdański Uniwersytet Medyczny, ul. Marii Skłodowskiej-Curie 3a, 80-210 Gdańsk
3 shared publications - Martyna Michalska
Department and Clinic of Geriatrics, and Internal Medicine Nicolaus Copernicus University in Toruń Ludwik Rydygier Collegium Medicum in Bydgoszcz, ul. Marii Skłodowskiej-Curie 9, 85-094 Bydgoszcz, Poland
2 shared publications - Adam Łabuda
Klinika Chorób Wewnętrznych, Chorób Zakaźnych i Alergologii, 5 Wojskowy Szpital Kliniczny z Polikliniką SPZOZ, Kraków, Polska
1 shared publication
Latest Publications
- Open Access
- 11 May 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 41, 60070
Automated Recognition of Abnormalities in Gastrointestinal Endoscopic Images – Evaluation of an AI Tool for Identifying Polyps and Other Irregularities
This study investigates the application of artificial intelligence (AI) for the automatic detection of pathological abnormalities in gastrointestinal endoscopic images. Specifically, it evaluates the performance of an AI tool in identifying and classifying lesions such as polyps and other irregularities, including inflammatory changes, within real-time endoscopic procedures. The primary objective is to assess the tool's diagnostic accuracy and its potential to improve lesion detection, thereby reducing the likelihood of overlooked abnormalities. Leveraging advanced machine learning techniques, particularly convolutional neural networks (CNNs), the AI system aims to enhance diagnostic precision and support clinicians in making prompt, evidence-based decisions. Key advantages of AI integration in endoscopy include improved sensitivity, minimized detection errors, and the potential to optimize clinical workflow efficiency. However, the study also addresses significant challenges, including the necessity for large, heterogeneous datasets for model validation, the need for standardized AI applications, and the ethical implications of AI-assisted clinical decision-making. Additionally, the potential benefits of combining AI with complementary imaging technologies, such as fluorescence imaging and spectroscopy, are explored to further enhance diagnostic capabilities. In conclusion, the study highlights the promising role of AI in gastrointestinal endoscopy while underscoring the importance of continued research, algorithmic refinement, and the establishment of regulatory frameworks to fully harness its clinical potential.
- 11 May 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 41, 60070
Open AccessAutomated Recognition of Abnormalities in Gastrointestinal Endoscopic Images – Evaluation of an AI Tool for Identifying Polyps and Other Irregularities
This study investigates the application of artificial intelligence (AI) for the automatic detection of pathological abnormalities in gastrointestinal endoscopic images. Specifically, it evaluates the performance of an AI tool in identifying and classifying lesions such as polyps and other irregularities, including inflammatory changes, within real-time endoscopic procedures. The primary objective is to assess the tool's diagnostic accuracy and its potential to improve lesion detection, thereby reducing the likelihood of overlooked abnormalities. Leveraging advanced machine learning techniques, particularly convolutional neural networks (CNNs), the AI system aims to enhance diagnostic precision and support clinicians in making prompt, evidence-based decisions. Key advantages of AI integration in endoscopy include improved sensitivity, minimized detection errors, and the potential to optimize clinical workflow efficiency. However, the study also addresses significant challenges, including the necessity for large, heterogeneous datasets for model validation, the need for standardized AI applications, and the ethical implications of AI-assisted clinical decision-making. Additionally, the potential benefits of combining AI with complementary imaging technologies, such as fluorescence imaging and spectroscopy, are explored to further enhance diagnostic capabilities. In conclusion, the study highlights the promising role of AI in gastrointestinal endoscopy while underscoring the importance of continued research, algorithmic refinement, and the establishment of regulatory frameworks to fully harness its clinical potential.
- Open Access
- 14 January 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 37, 57301
The role of Artificial Intelligence in detecting breast lesions using ultrasound
Introduction and objective: Breast cancer is the most diagnosed cancer and the second leading cause of cancer deaths in women globally, with rising cases and mortality. Early detection via mammography, ultrasound, or MRI is vital, with ultrasound excelling in dense breast tissue due to its safety and accuracy.Review methods: A literature review utilizing databases like Scopus, Google Scholar, and PubMed, with keywords such as "AI use in radiology" and "BI-RADS scale" underscores the need for advancements in understanding and managing graft rejection.Brief knowledge status: AI develops systems that simulate human intelligence, excelling in breast imaging by detecting patterns and providing accurate results. Machine learning (ML) and deep learning (DL) drive advances, with DL's CNNs leading in image analysis. AI aids BI-RADS lesion classification, ultrasound lesion detection, lymph node analysis, and treatment response prediction, often surpassing radiologists. Its future relies on real-world validation, improved outcomes, and clinical integration.Discussion: The integration of artificial intelligence (AI) into breast imaging marks a transformative leap in diagnostic radiology, enhancing precision, efficiency, and scalability. Driven by advancements in machine learning (ML) and deep learning (DL), AI excels in analyzing complex datasets. However, its clinical adoption requires addressing key considerations with a nuanced approach.Summary: In conclusion, AI holds immense promise in breast imaging, poised to redefine the field through enhanced diagnostic capabilities and clinical utility. Continued advancements and validation efforts will ensure its broader acceptance and sustained impact in medical imaging.
- 14 January 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 37, 57301
Open AccessThe role of Artificial Intelligence in detecting breast lesions using ultrasound
Introduction and objective: Breast cancer is the most diagnosed cancer and the second leading cause of cancer deaths in women globally, with rising cases and mortality. Early detection via mammography, ultrasound, or MRI is vital, with ultrasound excelling in dense breast tissue due to its safety and accuracy.Review methods: A literature review utilizing databases like Scopus, Google Scholar, and PubMed, with keywords such as "AI use in radiology" and "BI-RADS scale" underscores the need for advancements in understanding and managing graft rejection.Brief knowledge status: AI develops systems that simulate human intelligence, excelling in breast imaging by detecting patterns and providing accurate results. Machine learning (ML) and deep learning (DL) drive advances, with DL's CNNs leading in image analysis. AI aids BI-RADS lesion classification, ultrasound lesion detection, lymph node analysis, and treatment response prediction, often surpassing radiologists. Its future relies on real-world validation, improved outcomes, and clinical integration.Discussion: The integration of artificial intelligence (AI) into breast imaging marks a transformative leap in diagnostic radiology, enhancing precision, efficiency, and scalability. Driven by advancements in machine learning (ML) and deep learning (DL), AI excels in analyzing complex datasets. However, its clinical adoption requires addressing key considerations with a nuanced approach.Summary: In conclusion, AI holds immense promise in breast imaging, poised to redefine the field through enhanced diagnostic capabilities and clinical utility. Continued advancements and validation efforts will ensure its broader acceptance and sustained impact in medical imaging.
- Open Access
- 16 December 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 35, 56443
Advancements in Corneal Transplantation: Addressing Rejection Risks, Innovations and Challenges
Introduction and Objective: Corneal transplantation is an increasingly common surgical procedure, with lamellar keratoplasty now favored over penetrating keratoplasty due to its advantages in outcomes and precision. Review methods: A literature review utilizing databases like Scopus, Google Scholar, and PubMed, with keywords such as "corneal transplantation rejection" and "high risk of rejection," underscores the need for advancements in understanding and managing graft rejection. Brief knowledge status: Key insights highlight the importance of deeper exploration into the immunological mechanisms of rejection to refine therapeutic strategies. The development of bioengineered materials like acellular porcine corneal stroma (APCS) offers a promising solution to the global donor shortage, though further validation of their clinical utility is needed. Complementary therapies such as amniotic membrane transplantation show promise in mitigating graft failure and treating corneal surface disorders due to their anti-inflammatory and regenerative properties. Moreover, comparative studies suggest that advanced keratoplasty techniques, such as Descemet Membrane Endothelial Keratoplasty (DMEK), may achieve lower rejection rates compared to alternatives like Descemet Stripping Automated Endothelial Keratoplasty (DSAEK). Discussion: Future priorities include advancing drug delivery systems, ensuring the feasibility and accessibility of bioengineered materials, and conducting large-scale multicenter trials to validate novel treatments and surgical methods across diverse populations. Summary: Addressing these challenges is particularly crucial for high-risk and pediatric patients, with the ultimate goal of reducing graft failure rates and the necessity for repeat interventions.
- 16 December 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 35, 56443
Open AccessAdvancements in Corneal Transplantation: Addressing Rejection Risks, Innovations and Challenges
Introduction and Objective: Corneal transplantation is an increasingly common surgical procedure, with lamellar keratoplasty now favored over penetrating keratoplasty due to its advantages in outcomes and precision. Review methods: A literature review utilizing databases like Scopus, Google Scholar, and PubMed, with keywords such as "corneal transplantation rejection" and "high risk of rejection," underscores the need for advancements in understanding and managing graft rejection. Brief knowledge status: Key insights highlight the importance of deeper exploration into the immunological mechanisms of rejection to refine therapeutic strategies. The development of bioengineered materials like acellular porcine corneal stroma (APCS) offers a promising solution to the global donor shortage, though further validation of their clinical utility is needed. Complementary therapies such as amniotic membrane transplantation show promise in mitigating graft failure and treating corneal surface disorders due to their anti-inflammatory and regenerative properties. Moreover, comparative studies suggest that advanced keratoplasty techniques, such as Descemet Membrane Endothelial Keratoplasty (DMEK), may achieve lower rejection rates compared to alternatives like Descemet Stripping Automated Endothelial Keratoplasty (DSAEK). Discussion: Future priorities include advancing drug delivery systems, ensuring the feasibility and accessibility of bioengineered materials, and conducting large-scale multicenter trials to validate novel treatments and surgical methods across diverse populations. Summary: Addressing these challenges is particularly crucial for high-risk and pediatric patients, with the ultimate goal of reducing graft failure rates and the necessity for repeat interventions.
- Open Access
- 15 November 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 32, 56082
Colostrum: The Golden Elixir of Health – Unveiling Its Multifaceted Benefits in Modern Medicine
Introduction: Colostrum is uniquely rich in immunoglobulins, growth factors, antibacterial peptides, probiotics, prebiotics, and essential vitamins and minerals. Available as a supplement, BC is used to prevent gastrointestinal infections, boost immune support, and aid in managing chronic inflammation, autoimmune diseases, and even athletic recovery. Aim: The aim of this article is to assess the potential benefits of colostrum across various health areas, including gastrointestinal health, immune system support, respiratory diseases, dermatology, autoimmune conditions and the development of preterm infants. The article will also present a critical analysis of current scientific data and examine future research directions and therapeutic advancements. Review methods: This article is based on a comprehensive, non-systematic review of the scientific literature. A thorough search of the PubMed database was conducted, and 45 sources published up to 2024 were analyzed to ensure that the information presented is current and relevant. Abbreviated description of the state of knowledge: Analysis of the literature suggests that colostrum may provide passive protection, reduce inflammation and support gut integrity in preterm infants. Inflammatory bowel disease may benefit from colostrum, though results for IBS are mixed. It aids wound healing, has anti-aging effects, and shows potential in autoimmune disease management. It also boosts respiratory immunity and aids athletes' recovery and performance. Conclusions: Colostrum contains bioactive components like immunoglobulins, lactoferrin, and growth factors. While current studies highlight its benefits in enhancing immunity, supporting gut health, and managing inflammatory conditions, more comprehensive clinical trials are required to confirm its efficacy and safety across various populations and health conditions.
- 15 November 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 32, 56082
Open AccessColostrum: The Golden Elixir of Health – Unveiling Its Multifaceted Benefits in Modern Medicine
Introduction: Colostrum is uniquely rich in immunoglobulins, growth factors, antibacterial peptides, probiotics, prebiotics, and essential vitamins and minerals. Available as a supplement, BC is used to prevent gastrointestinal infections, boost immune support, and aid in managing chronic inflammation, autoimmune diseases, and even athletic recovery. Aim: The aim of this article is to assess the potential benefits of colostrum across various health areas, including gastrointestinal health, immune system support, respiratory diseases, dermatology, autoimmune conditions and the development of preterm infants. The article will also present a critical analysis of current scientific data and examine future research directions and therapeutic advancements. Review methods: This article is based on a comprehensive, non-systematic review of the scientific literature. A thorough search of the PubMed database was conducted, and 45 sources published up to 2024 were analyzed to ensure that the information presented is current and relevant. Abbreviated description of the state of knowledge: Analysis of the literature suggests that colostrum may provide passive protection, reduce inflammation and support gut integrity in preterm infants. Inflammatory bowel disease may benefit from colostrum, though results for IBS are mixed. It aids wound healing, has anti-aging effects, and shows potential in autoimmune disease management. It also boosts respiratory immunity and aids athletes' recovery and performance. Conclusions: Colostrum contains bioactive components like immunoglobulins, lactoferrin, and growth factors. While current studies highlight its benefits in enhancing immunity, supporting gut health, and managing inflammatory conditions, more comprehensive clinical trials are required to confirm its efficacy and safety across various populations and health conditions.